Multimillion cash investment injected into the global nanodrug market

By leon-nanodrugs GmbH

Based on an €18.5-million investment, with an additional €3.0 million expected later in 2015, under the lead of TVM Capital Life Sciences, a global VC company in life sciences, leon-nanodrugs is starting its international expansion, particularly into the US and China, with a focus on the co-development of nanotechnology based reformulations of brands and generics. CSO and co-founder Dr Wolfgang Beier answers World Pharmaceutical Frontiers’ questions.

Enter your details below to view the free whitepaper

By downloading this Whitepaper, you acknowledge that may share your information with our white paper partners/sponsors who may contact you directly with information on their products and services.

Visit our Privacy Policy for more information about our services, how Business Trade Media International Limited may use, process and share your personal data, including information on your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.